Please use this identifier to cite or link to this item:
|Title:||p53 Expression in gestational trophoblastic disease||Authors:||Lee, Y.-S.||Keywords:||Decidual cells
|Issue Date:||1995||Citation:||Lee, Y.-S. (1995). p53 Expression in gestational trophoblastic disease. International Journal of Gynecological Pathology 14 (2) : 119-124. ScholarBank@NUS Repository.||Abstract:||The p53 expression of normal trophoblasts (11 cases), partial moles (11 cases), complete moles (19 cases), and gestational choriocarcinoma (eight cases) were studied. We found that p53 is frequently expressed in gestational choriocarcinoma and in hydatidiform moles (mainly cytotrophoblasts), whereas syncytiotrophoblasts are generally spared. This finding supports the view that p53 expression is a reflection of proliferative capacity of cells rather than an indicator of neoplastic or malignant transformation. The greater p53 expression observed in complete moles as compared with partial moles is in keeping with the more pronounced trophoblastic hyperplasia and proliferative activity of complete moles. More interesting was the observation that p53 expression was also noted in normal trophoblasts, secretory endometrial glands, and decidual cells of the stroma. Therefore, it appears that the immunohistochemical expression of p53 can occur in a variety of situations, including neoplastic, proliferative, and nonproliferative conditions. Although p53 mutations are often the basis of excessive accumulation of mutant p53 protein in malignancies, other mechanisms may be involved in nonneoplastic conditions. These findings emphasize the need for caution in the interpretation of immunohistochemical expression of p53 protein.||Source Title:||International Journal of Gynecological Pathology||URI:||http://scholarbank.nus.edu.sg/handle/10635/131114||ISSN:||02771691|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on May 21, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.